Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Abstract

BACKGROUND Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yielded conflicting conclusions. AIMS The purpose of this meta-analysis was to provide a more precise estimate… (More)
DOI: 10.1136/gut.2004.049460

Topics

5 Figures and Tables

Slides referencing similar topics